In order assess the time to corneal epithelization with photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) as a first-line treatment for early infectious corneal ulcers and to compare PACK-CXL with antimicrobial therapy, the current standard of care, instigators conducted a prospective, interventional, multicenter, randomized phase III clinical trial. Corneal re-epithelization times were compared between patients with infiltrates and early ulcers up to 4 mm in diameter and 300 μm deep who were randomized to PACK-CXL or antimicrobials. No differences in re-epithelization were seen between the antimicrobial and PACK-CXL groups, with a median time to epithelization of 7 days forth both. However, 89% of eyes treated with PACK-CXL healed without the use of antimicrobial therapy, even with a tendency for longer healing than seen in the antimicrobial group, in which 93% of eyes healed with the use of antimicrobials. PACK-CXL could prove particularly useful in treating drug-resistant pathogen, said the presenting study author.
September 1, 2020
June 3, 2020
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.
- CROI 2020Every year, CROI hosts some of the world's leading experts in HIV research, who come to present exciting new data and drive forward the field of HIV/AIDS research. This year, due to COVID-19, CROI held their meeting virtually.